N.Y. Man Will Appeal Award of Summary Judgment to Janssen in Risperdal Case

NEW YORK — A New York man is appealing an award of summary judgment to Janssen Pharmaceuticals Inc. in a Risperdal lawsuit, challenging the judge’s findings that there was a lack of evidence that the drug contains a design defect.

According to the Sept. 26 notice of appeal filed in the U.S. District Court for the Southern District of New York, the 2nd Circuit U.S. Court of Appeals will review the trial court’s findings.

Jamal Adeghe was prescribed Risperdal when he was 10 to treat his depressive symptoms, impulse control and aggression. He was later diagnosed with gynecomastia — the …